Boviseal 2.6 g Intramammary Suspension for Cattle (Dairy Cows)

Држава: Велика Британија

Језик: Енглески

Извор: VMD (Veterinary Medicines Directorate)

Активни састојак:

Bismuth Subnitrate

Доступно од:

Continental Farmaceutica

АТЦ код:

QG52X

INN (Међународно име):

Bismuth Subnitrate

Фармацеутски облик:

Intramammary suspension

Тип рецептора:

POM-V - Prescription Only Medicine – Veterinarian

Терапеутска група:

Cattle

Терапеутска област:

Miscellaneous mechanical teat seal

Статус ауторизације:

Expired

Датум одобрења:

2013-01-23

Карактеристике производа

Revised: February 2018
AN: 01624/2016
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
UK - BOVISEAL 2.6 g intramammary suspension for cattle (dairy cows)
Italy, Spain - EASISEAL 2.6 g intramammary suspension for cattle
(dairy cows)
France - MAMISEAL 2.6 g intramammary suspension for cattle (dairy
cows)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4g intramammary syringe contains:
ACTIVE SUBSTANCE: Bismuth subnitrate, heavy2.6g
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Intramammary suspension
Greyish white, smooth, unctuous cream.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (dairy cows).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Prevention of new intramammary infections throughout the dry period.
In cows considered likely to be free of sub-clinical mastitis, the
product can be used
on its own in dry cow management and mastitis control.
Selection of cows for treatment with the product should be based on
veterinary
clinical judgement. Selection criteria may be based on the mastitis
and cell count
history of individual cows, or recognised tests for the detection of
sub-clinical mastitis
or bacteriological sampling.
4.3
CONTRAINDICATIONS
See section 4.7. Do not use the product alone in cows with
sub-clinical mastitis at
drying off. Do not use in cows with clinical mastitis at drying off.
Do not use in the lactating cows.
Do not use in known cases of hypersensitivity to bismuth subnitrate or
any of the
excipients.
Revised: February 2018
AN: 01624/2016
Page 2 of 5
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
It is good practice to observe dry cows regularly for signs of
clinical mastitis.
If a sealed quarter develops clinical mastitis the affected quarter
should be stripped
out manually before appropriate antibacterial therapy is instituted.
Cows considered likely to be free of subclinical mastitis should be
given the
veterinary medicinal product at